Skip to main content
Fig. 6 | BMC Pharmacology and Toxicology

Fig. 6

From: Analysis of lung cancer-related genetic changes in long-term and low-dose polyhexamethylene guanidine phosphate (PHMG-p) treated human pulmonary alveolar epithelial cells

Fig. 6

RT-qPCR validation for downregulated protein coding genes in the long-term treatment group. To validate the upregulated candidate genes on total RNA sequencing, the expression of NDUFA4L2, SLITRK6, TIMP3, FMO3, HBG1, MGP, HBG2, TBX4, GPX3, and FMO2 was determined by RT-qPCR. All selected genes were verified to be decreased in the long-term treatment group. All experiments were performed 3 times with technical replicates

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us